HealthEquity Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|
| Revenue | $229.5M | $178.4M | $126.8M | $87.9M | $62.0M | $46.1M |
| Cost of Revenue | $94.6M | $72.0M | — | — | — | — |
| Gross Profit | $134.9M | $106.4M | $72.6M | $48.0M | $32.8M | $24.1M |
| Gross Margin | 58.8% | 59.6% | 57.3% | 54.6% | 52.9% | 52.3% |
| Operating Expenses | ||||||
| Research & Development | $27.4M | $22.4M | $16.8M | $10.5M | $7.1M | $4.2M |
| SG&A Expense | $25.1M | $20.2M | $14.1M | $8.3M | $3.9M | $3.4M |
| Operating Income | $54.4M | $41.2M | $26.1M | $16.9M | $11.5M | $7.1M |
| Operating Margin | 23.7% | 23.1% | 20.6% | 19.2% | 18.6% | 15.4% |
| Interest Expense | $274.0K | — | — | $0 | $44.0K | $326.0K |
| Pretax Income | $52.2M | $40.1M | $25.6M | $15.8M | $5.4M | $6.5M |
| Income Tax Expense | $4.8M | $13.7M | $8.9M | $5.6M | $4.1M | $-4.7M |
| Net Income | $47.4M | $26.4M | $16.6M | $10.2M | $1.2M | $11.2M |
| Net Margin | 20.6% | 14.8% | 13.1% | 11.6% | 2.0% | 24.2% |
| EPS (Basic) | $0.79 | $0.45 | $0.29 | $0.39 | $-0.14 | $0.09 |
| EPS (Diluted) | $0.77 | $0.44 | $0.28 | $0.21 | $-0.14 | $0.03 |
| Shares Outstanding (Basic) | 60.3M | 58.6M | 56.7M | 31.2M | 50.9M | 44.3M |
| Shares Outstanding (Diluted) | 61.9M | 59.9M | 58.9M | 51.9M | 50.9M | 337.6M |
| Dividends Per Share | — | — | — | — | — | — |